WMT

132.09

+3.26%↑

COST

1,013.73

+1.6%↑

147.32

+0.66%↑

165.04

+1.53%↑

PEP

158.39

+2.11%↑

WMT

132.09

+3.26%↑

COST

1,013.73

+1.6%↑

147.32

+0.66%↑

165.04

+1.53%↑

PEP

158.39

+2.11%↑

WMT

132.09

+3.26%↑

COST

1,013.73

+1.6%↑

147.32

+0.66%↑

165.04

+1.53%↑

PEP

158.39

+2.11%↑

WMT

132.09

+3.26%↑

COST

1,013.73

+1.6%↑

147.32

+0.66%↑

165.04

+1.53%↑

PEP

158.39

+2.11%↑

WMT

132.09

+3.26%↑

COST

1,013.73

+1.6%↑

147.32

+0.66%↑

165.04

+1.53%↑

PEP

158.39

+2.11%↑

Home・Aktien・USANA Health Sciences Inc

USANA Health Sciences Inc

Geschlossen

19.06 2.2

Buy Sell

Übersicht

Veränderung der Aktienkurses

24h

Aktuell

Min

18.31

Max

19.19

Schlüsselkennzahlen
By Trading Economics
Einkommen	5.1M -1.6M
Verkäufe	13M 226M
KGV Branchendurchschnitt	33.414 28.392
Gewinnspanne	-0.705
Angestellte	1,570
EBITDA	16M 28M

Dividenden
By Dow Jones
Nächstes Ergebnis	5. Mai 2026

Marktstatistiken
By TradingEconomics
Marktkapitalisierung	-24M 358M
Vorheriger Eröffnungskurs	16.86
Vorheriger Schlusskurs	19.06

Technischer Score

By Trading Central

Vertrauen

Weak Bullish Evidence

28.405 / 29.84 Unterstützung & Widerstand

USANA Health Sciences Inc Chart

Vergangene Performances sind kein verlässlicher Indikator für zukünftige Ergebnisse.

Ähnliche Nachrichten

30. Apr. 2026, 23:08 UTC

Ergebnisse

Australia's ANZ Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

30. Apr. 2026, 23:07 UTC

Ergebnisse

Australia's Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

30. Apr. 2026, 22:20 UTC

Ergebnisse

Australia's ANZ Raises 1st Half Profit 9%, Warns of Coming Iran Impacts

30. Apr. 2026, 23:48 UTC

Market Talk

Nikkei May Rise After Gains on Wall Street -- Market Talk

30. Apr. 2026, 23:47 UTC

Market Talk

Global Equities Roundup: Market Talk

30. Apr. 2026, 23:47 UTC

Market Talk

Coles's Earnings Views Likely to Edge Down Despite Positives -- Market Talk

30. Apr. 2026, 23:27 UTC

Market Talk

Liontown Lithium Recovery Expected to Improve -- Market Talk

30. Apr. 2026, 23:22 UTC

Ergebnisse

Apple's Incoming CEO John Ternus Makes Appearance as Company Bests Expectations -- Update

30. Apr. 2026, 23:20 UTC

Market Talk

Wildcat Resources Stands Out Among Lithium Developers -- Market Talk

30. Apr. 2026, 22:52 UTC

Ergebnisse

Australia's ANZ Warns of Coming Iran Impacts as First-Half Profit Rises -- Update

30. Apr. 2026, 22:33 UTC

Ergebnisse

Zhejiang Expressway: Impairment Loss Weighed on Net >0576.HK

30. Apr. 2026, 22:32 UTC

Ergebnisse

Zhejiang Expressway 1Q Net CNY1.31B Vs. Net CNY1.48B >0576.HK

30. Apr. 2026, 22:32 UTC

Ergebnisse

Zhejiang Expressway 1Q Rev CNY5.32B Vs. CNY4.36B >0576.HK

30. Apr. 2026, 22:24 UTC

Akquisitionen, Fusionen, Übernahmen

Mineral Resources: Also Reflects Time Needed to Implement Corporate Restructure For JV

30. Apr. 2026, 22:23 UTC

Akquisitionen, Fusionen, Übernahmen

Mineral Resources: Revised Timetable Reflects Time Needed to Get Regulatory Approvals

30. Apr. 2026, 22:23 UTC

Akquisitionen, Fusionen, Übernahmen

Mineral Resources: Now Expects Deal to Complete in 1H FY2027

30. Apr. 2026, 22:23 UTC

Akquisitionen, Fusionen, Übernahmen

Mineral Resources: Executes Key Formal Agreements With Posco on Stake Sale

30. Apr. 2026, 22:11 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30. Apr. 2026, 22:11 UTC

Market Talk

Global Equities Roundup: Market Talk

30. Apr. 2026, 22:11 UTC

Market Talk

Apple Says Demand for Lower-Cost Laptop is Off the Charts -- Market Talk

30. Apr. 2026, 22:05 UTC

Ergebnisse

Australia's ANZ Raises 1H Profit 9%, Warns of Coming Iran Impacts

30. Apr. 2026, 21:57 UTC

Ergebnisse

ANZ CEO: Increase in Collective Provisions Reflects Risk>ANZ.AU

30. Apr. 2026, 21:56 UTC

Ergebnisse

ANZ CEO: Minimal Impact on ANZ's Credit, Capital, Liquidity>ANZ.AU

30. Apr. 2026, 21:56 UTC

Ergebnisse

ANZ CEO: No Material Increase in New Cases of Household Hardship>ANZ.AU

30. Apr. 2026, 21:55 UTC

Ergebnisse

ANZ CEO: Households Entered Crisis With Generally Strong Balance Sheets>ANZ.AU

30. Apr. 2026, 21:54 UTC

Ergebnisse

ANZ CEO: No Material Change in Overall Corporate Borrowing Behavior >ANZ.AU

30. Apr. 2026, 21:54 UTC

Ergebnisse

ANZ CEO: Corporate Customers Have Been Building Capital, Liquidity Against Shocks>ANZ.AU

30. Apr. 2026, 21:53 UTC

Ergebnisse

ANZ CEO: Much of Iran Conflict's Potential Impact Remains Ahead>ANZ.AU

30. Apr. 2026, 21:49 UTC

Ergebnisse

ANZ Group 1H Total Operating Income A$11.20B Vs. A$10.995B>ANZ.AU

30. Apr. 2026, 21:49 UTC

Ergebnisse

ANZ Group 1H Customer Deposits A$770.7B Vs. A$756.6B>ANZ.AU

Peer-Vergleich

Kursveränderung

USANA Health Sciences Inc Prognose

Rating-Konsens

By TipRanks

0 ratings

Buy

Halten

Sell

Basierend auf 0 Analysten, die in den letzten 3 Monaten Aktienbewertungen für USANA Health Sciences Inc – Dist abgegeben haben.

Technischer Score

By Trading Central

28.405 / 29.84Unterstützung & Widerstand

Bullish events outweigh bearish events.

Recent bullish events outweigh bearish events.

There are no events.

Finanzen

Vertriebs- und Verwaltungskosten

Betriebsaufwand

Gewinn vor Steuern

Verkäufe

Umsatzkosten

Bruttogewinn aus dem Verkauf

Zinsaufwand für Schulden

EBITDA

Betriebsergebnis

Über USANA Health Sciences Inc

USANA Health Sciences, Inc. develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products. It also provides Celavive, a skin care regimen for various skin care types and ethnicities; and other products for prenatal, infant, and young child age groups. In addition, the company offers materials and online tools to assist associates in building their businesses, as well as in marketing products. It offers its products through retail stores and online. The company has a research collaboration agreement with Beijing University of Chinese Medicine; and National Sports Training Bureau. USANA Health Sciences, Inc. was founded in 1992 and is headquartered in Salt Lake City, Utah.